Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exogen Biotechnology is a Berkeley-based life sciences company specializing in the quantification of DNA damage and repair at the single-cell level. The company's proprietary technology platform allows for the precise measurement of DNA strand breaks, providing a functional readout of an individual's genomic stability and environmental exposure. By bridging the gap between genetic predisposition and actual DNA health, Exogen offers tools for researchers and clinicians to monitor the impact of lifestyle, aging, and medical treatments on genomic integrity. Their services are primarily utilized in pharmaceutical R&D, occupational health monitoring, and personalized wellness applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Exogen.